Skip to main content
Top
Published in: Internal and Emergency Medicine 2/2020

01-03-2020 | Hypertension | IM - ORIGINAL

Cost-effectiveness analysis of different hypertension management strategies in a community setting

Authors: Xin Zhang, Hang Liao, Di Shi, Xinran Li, Xiaoping Chen, Sen He

Published in: Internal and Emergency Medicine | Issue 2/2020

Login to get access

Abstract

Self-management schemes and mobile apps can be used for the management of hypertension in the community, but the most appropriate patient population is unknown. To explore whether the Chinese Health Literacy Scale (CHLSH) can be used to screen for appropriate patients with hypertension for self-management and to evaluate the clinical effectiveness and health economic evaluation of three hypertension management schemes. This was a prospective study performed from March 2017 to July 2017 in consecutive patients with primary hypertension and of 50–80 years of age from the Jinyang community, Wuhou District, Chengdu. The CHLSH was completed and the patients were classified into the high (n = 283) and low (n = 315) health literacy groups. The patients were randomly divided into the self-management, traditional management, and mobile app management groups. The high-health literacy group was selected to construct the cost-effectiveness decision tree model. Blood pressure control rate and the quality-adjusted life years (QALYs) were determined. At the end of follow-up, the success rate of self-management was 83.4%. The costs for 6 months of treatment for each patient with hypertension in the self-management, traditional management, and mobile app groups were 1266, 1751, and 1856 yuan, respectively. The costs required for obtaining 1 QALY when managing for 6 months were: 30,869 yuan for self-management; 48,628 yuan for traditional management; and 43,199 yuan for the mobile app. The CHLSH can be used as a tool for screening patients with hypertension for self-management. The cost-effectiveness of self-management was optimal.
Literature
1.
go back to reference Bundy JD, He J (2016) Hypertension and related cardiovascular disease burden in China. Ann Glob Health 82:227–233CrossRef Bundy JD, He J (2016) Hypertension and related cardiovascular disease burden in China. Ann Glob Health 82:227–233CrossRef
2.
go back to reference Li H, Ge J (2015) Cardiovascular diseases in China: current status and future perspectives. Int J Cardiol Heart Vasc 6:25–31CrossRef Li H, Ge J (2015) Cardiovascular diseases in China: current status and future perspectives. Int J Cardiol Heart Vasc 6:25–31CrossRef
3.
go back to reference Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG et al (2012) Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007–2008 China national diabetes and metabolic disorders study. Eur Heart J 33:213–220CrossRef Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG et al (2012) Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007–2008 China national diabetes and metabolic disorders study. Eur Heart J 33:213–220CrossRef
4.
go back to reference Lu CH, Tang ST, Lei YX, Zhang MQ, Lin WQ et al (2015) Community-based interventions in hypertensive patients: a comparison of three health education strategies. BMC Public Health 15:33CrossRef Lu CH, Tang ST, Lei YX, Zhang MQ, Lin WQ et al (2015) Community-based interventions in hypertensive patients: a comparison of three health education strategies. BMC Public Health 15:33CrossRef
5.
go back to reference Kaczorowski J, Del Grande C, Nadeau-Grenier V (2013) Community-based programs to improve prevention and management of hypertension: recent Canadian experiences, challenges, and opportunities. Can J Cardiol 29:571–578CrossRef Kaczorowski J, Del Grande C, Nadeau-Grenier V (2013) Community-based programs to improve prevention and management of hypertension: recent Canadian experiences, challenges, and opportunities. Can J Cardiol 29:571–578CrossRef
6.
go back to reference Ferdinand KC, Patterson KP, Taylor C, Fergus IV, Nasser SA et al (2012) Community-based approaches to prevention and management of hypertension and cardiovascular disease. J Clin Hypertens (Greenwich) 14:336–343CrossRef Ferdinand KC, Patterson KP, Taylor C, Fergus IV, Nasser SA et al (2012) Community-based approaches to prevention and management of hypertension and cardiovascular disease. J Clin Hypertens (Greenwich) 14:336–343CrossRef
7.
go back to reference Kong X, Yang Y (2015) The current status and challenges of community general practitioner system building in China. QJM 108:89–91CrossRef Kong X, Yang Y (2015) The current status and challenges of community general practitioner system building in China. QJM 108:89–91CrossRef
8.
go back to reference Zou Y, Zhang X, Hao Y, Shi L, Hu R (2015) General practitioners versus other physicians in the quality of primary care: a cross-sectional study in Guangdong Province, China. BMC Fam Pract 16:134CrossRef Zou Y, Zhang X, Hao Y, Shi L, Hu R (2015) General practitioners versus other physicians in the quality of primary care: a cross-sectional study in Guangdong Province, China. BMC Fam Pract 16:134CrossRef
9.
go back to reference Whelton P, Granger JP, Ng L, Schiffrin EL, McFGadyen RJ et al (2007) Comprehensive hypertension. Mosby Inc, Philadelphia Whelton P, Granger JP, Ng L, Schiffrin EL, McFGadyen RJ et al (2007) Comprehensive hypertension. Mosby Inc, Philadelphia
10.
go back to reference Bosworth HB, Olsen MK, Grubber JM, Neary AM, Orr MM et al (2009) Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med 151:687–695CrossRef Bosworth HB, Olsen MK, Grubber JM, Neary AM, Orr MM et al (2009) Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med 151:687–695CrossRef
11.
go back to reference Hallberg I, Ranerup A, Kjellgren K (2016) Supporting the self-management of hypertension: patients' experiences of using a mobile phone-based system. J Hum Hypertens 30:141–146CrossRef Hallberg I, Ranerup A, Kjellgren K (2016) Supporting the self-management of hypertension: patients' experiences of using a mobile phone-based system. J Hum Hypertens 30:141–146CrossRef
12.
go back to reference Magid DJ, Farmer SA (2014) Hypertension self-management: a home run for patients and payers. Circ Cardiovasc Qual Outcomes 7:205–206CrossRef Magid DJ, Farmer SA (2014) Hypertension self-management: a home run for patients and payers. Circ Cardiovasc Qual Outcomes 7:205–206CrossRef
13.
go back to reference Kang H, Park HA (2016) A mobile app for hypertension management based on clinical practice guidelines: development and deployment. JMIR mhealth uhealth 4:e12CrossRef Kang H, Park HA (2016) A mobile app for hypertension management based on clinical practice guidelines: development and deployment. JMIR mhealth uhealth 4:e12CrossRef
14.
go back to reference Liang J, He X, Jia Y, Zhu W, Lei J (2018) Chinese mobile health apps for hypertension management: a systematic evaluation of usefulness. J Healthc Eng 2018:7328274PubMedPubMedCentral Liang J, He X, Jia Y, Zhu W, Lei J (2018) Chinese mobile health apps for hypertension management: a systematic evaluation of usefulness. J Healthc Eng 2018:7328274PubMedPubMedCentral
15.
go back to reference Shi D, Li J, Wang Y, Wang S, Liu K et al (2017) Association between health literacy and hypertension management in a Chinese community: a retrospective cohort study. Intern Emerg Med 12:765–776CrossRef Shi D, Li J, Wang Y, Wang S, Liu K et al (2017) Association between health literacy and hypertension management in a Chinese community: a retrospective cohort study. Intern Emerg Med 12:765–776CrossRef
16.
go back to reference Yilmazel G, Cetinkaya F (2017) Relation between health literacy levels, hypertension awareness and control among primary-secondary school teachers in Turkey. AIMS Public Health 4:314–325CrossRef Yilmazel G, Cetinkaya F (2017) Relation between health literacy levels, hypertension awareness and control among primary-secondary school teachers in Turkey. AIMS Public Health 4:314–325CrossRef
17.
go back to reference Halladay JR, Donahue KE, Cene CW, Li Q, Cummings DM et al (2017) The association of health literacy and blood pressure reduction in a cohort of patients with hypertension: the heart healthy lenoir trial. Patient Educ Couns 100:542–549CrossRef Halladay JR, Donahue KE, Cene CW, Li Q, Cummings DM et al (2017) The association of health literacy and blood pressure reduction in a cohort of patients with hypertension: the heart healthy lenoir trial. Patient Educ Couns 100:542–549CrossRef
18.
go back to reference Bobrow K, Farmer AJ, Springer D, Shanyinde M, Yu LM et al (2016) Mobile phone text messages to support treatment adherence in adults with high blood pressure (SMS-text adherence support [StAR]): a single-blind, randomized trial. Circulation 133:592–600PubMedPubMedCentral Bobrow K, Farmer AJ, Springer D, Shanyinde M, Yu LM et al (2016) Mobile phone text messages to support treatment adherence in adults with high blood pressure (SMS-text adherence support [StAR]): a single-blind, randomized trial. Circulation 133:592–600PubMedPubMedCentral
19.
go back to reference Wang JG (2012) Home blood pressure monitoring: a China consensus document. Chin J Hypertens 20:525–529 Wang JG (2012) Home blood pressure monitoring: a China consensus document. Chin J Hypertens 20:525–529
20.
go back to reference Tai BB, Bae YH, Le QA (2016) A Systematic review of health economic evaluation studies using the patient's perspective. Value Health 19:903–908CrossRef Tai BB, Bae YH, Le QA (2016) A Systematic review of health economic evaluation studies using the patient's perspective. Value Health 19:903–908CrossRef
21.
go back to reference Park S, Buranakitjaroen P, Chen CH, Chia YC, Divinagracia R et al (2018) Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia Network. J Hum Hypertens 32:249–258CrossRef Park S, Buranakitjaroen P, Chen CH, Chia YC, Divinagracia R et al (2018) Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia Network. J Hum Hypertens 32:249–258CrossRef
22.
go back to reference Luo N, Liu G, Li M, Guan H, Jin X et al (2017) Estimating an EQ-5D-5L value set for China. Value Health 20:662–669CrossRef Luo N, Liu G, Li M, Guan H, Jin X et al (2017) Estimating an EQ-5D-5L value set for China. Value Health 20:662–669CrossRef
23.
go back to reference Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I et al (2002) Estimating an EQ-5D population value set: the case of Japan. Health Econ 11:341–353CrossRef Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I et al (2002) Estimating an EQ-5D population value set: the case of Japan. Health Econ 11:341–353CrossRef
24.
go back to reference Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S et al (2016) Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res 25:707–719CrossRef Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S et al (2016) Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res 25:707–719CrossRef
25.
go back to reference Cohen DJ, Reynolds MR (2008) Interpreting the results of cost-effectiveness studies. J Am Coll Cardiol 52:2119–2126CrossRef Cohen DJ, Reynolds MR (2008) Interpreting the results of cost-effectiveness studies. J Am Coll Cardiol 52:2119–2126CrossRef
26.
go back to reference Jakubiak-Lasocka J, Jakubczyk M (2014) Cost-effectiveness versus cost-utility analyses: what are the motives behind using each and how do their results differ?-A polish example. Value Health Reg Issues 4:66–74CrossRef Jakubiak-Lasocka J, Jakubczyk M (2014) Cost-effectiveness versus cost-utility analyses: what are the motives behind using each and how do their results differ?-A polish example. Value Health Reg Issues 4:66–74CrossRef
27.
go back to reference Gibson JL, Martin DK, Singer PA (2005) Evidence, economics and ethics: resource allocation in health services organizations. Healthc Q 8(50–59):54 Gibson JL, Martin DK, Singer PA (2005) Evidence, economics and ethics: resource allocation in health services organizations. Healthc Q 8(50–59):54
28.
go back to reference Raina RS, Thawani V (2016) The Zest for Patient Empowerment. J Clin Diagn Res 10: FE01-03. Raina RS, Thawani V (2016) The Zest for Patient Empowerment. J Clin Diagn Res 10: FE01-03.
29.
go back to reference Owens DK (1998) Interpretation of cost-effectiveness analyses. J Gen Intern Med 13:716–717CrossRef Owens DK (1998) Interpretation of cost-effectiveness analyses. J Gen Intern Med 13:716–717CrossRef
30.
go back to reference Woods B, Revill P, Sculpher M, Claxton K (2016) Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health 19:929–935CrossRef Woods B, Revill P, Sculpher M, Claxton K (2016) Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health 19:929–935CrossRef
31.
go back to reference Vallejo-Torres L, Garcia-Lorenzo B, Castilla I, Valcarcel-Nazco C, Garcia-Perez L et al (2016) On the estimation of the cost-effectiveness threshold: Why, what, how? Value Health 19:558–566CrossRef Vallejo-Torres L, Garcia-Lorenzo B, Castilla I, Valcarcel-Nazco C, Garcia-Perez L et al (2016) On the estimation of the cost-effectiveness threshold: Why, what, how? Value Health 19:558–566CrossRef
32.
go back to reference McCabe C, Claxton K, Culyer AJ (2008) The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics 26:733–744CrossRef McCabe C, Claxton K, Culyer AJ (2008) The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics 26:733–744CrossRef
33.
go back to reference Carrera P, IJzerman MJ, (2016) Are current ICER thresholds outdated? Valuing medicines in the era of personalized healthcare. Expert Rev Pharmacoecon Outcomes Res 16:435–437CrossRef Carrera P, IJzerman MJ, (2016) Are current ICER thresholds outdated? Valuing medicines in the era of personalized healthcare. Expert Rev Pharmacoecon Outcomes Res 16:435–437CrossRef
34.
go back to reference Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S (2015) Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ 93:118–124CrossRef Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S (2015) Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ 93:118–124CrossRef
Metadata
Title
Cost-effectiveness analysis of different hypertension management strategies in a community setting
Authors
Xin Zhang
Hang Liao
Di Shi
Xinran Li
Xiaoping Chen
Sen He
Publication date
01-03-2020
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 2/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02146-9

Other articles of this Issue 2/2020

Internal and Emergency Medicine 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine